| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,259,821 |
|
|
|
Indirect Value
|
$148,965,006 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$150,224,827 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-10-14 |
4 |
A |
$0.00 |
$2,999,992 |
I/I |
3,208,835 |
263,750 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2023-11-15 |
4 |
B |
$0.80 |
$1,102,718 |
D/D |
1,370,688 |
2,180,297 |
2.81 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,097,810 |
1,061,833 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,097,810 |
1,100,848 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-19 |
4 |
B |
$3.78 |
$1,134,510 |
D/D |
300,000 |
809,609 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
PRESIDENT & CEO |
• • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
270,339 |
2,811,004 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,500 |
796,333 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
265,500 |
1,366,348 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-24 |
4 |
A |
$0.00 |
$0 |
I/I |
265,500 |
1,631,848 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,500 |
530,833 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,500 |
265,333 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-25 |
4 |
A |
$0.00 |
$0 |
I/I |
265,500 |
1,897,348 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,333 |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-26 |
4 |
A |
$0.00 |
$0 |
I/I |
265,333 |
2,162,681 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2023-11-16 |
4 |
B |
$1.00 |
$261,514 |
D/D |
262,433 |
2,442,730 |
2.81 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-10-26 |
4 |
S |
$46.00 |
$10,136,507 |
D/D |
(220,000) |
1,031,553 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-18 |
4 |
B |
$3.72 |
$768,046 |
D/D |
206,198 |
509,609 |
2.81 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-10-26 |
4 |
OE |
$8.94 |
$1,788,500 |
D/D |
200,000 |
1,251,553 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
198,124 |
198,124 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-05-06 |
4 |
OE |
$7.41 |
$1,381,305 |
D/D |
186,504 |
634,686 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-05-06 |
4 |
S |
$38.40 |
$7,166,914 |
D/D |
(186,504) |
477,150 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-07-24 |
4 |
S |
$48.00 |
$8,661,324 |
D/D |
(180,448) |
1,050,156 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
S |
$35.00 |
$6,335,590 |
D/D |
(180,000) |
415,550 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
OE |
$7.30 |
$1,313,442 |
D/D |
180,000 |
595,550 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-02-04 |
4 |
S |
$52.43 |
$9,096,634 |
D/D |
(173,452) |
1,076,525 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
